☰ Menu

Most important publications

Show all articles on Pubmed

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia (T-PLL)

Staber, Philipp B.Herling, MarcoBellido, MarJacobsen, Eric D.Davids, Matthew S.Kadia, Tapan MahendraShustov, AndreiTournilhac, OlivierBachy, EmmanuelZaja, FrancescoPorkka, KimmoHoermann, GregorSimonitsch, IngridHaferlach, ClaudiaKubicek, StefanMayerhoefer, MariusHopfinger, GeorgJaeger, UlrichDearden, ClaireBlood, 2019

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

Schrader, A Crispatzu, G Oberbeck, S Mayer, P Pützer, S von Jan, J Vasyutina, E Warner, K Weit, N Pflug, N Braun, T Andersson, EI Yadav, B Riabinska, A Maurer, B Ventura Ferreira, MS Beier, F Altmüller, J Lanasa, M Herling, CD Haferlach, T Stilgenbauer, S Hopfinger, G Peifer, M Brümmendorf, TH Nürnberg, P Elenitoba-Johnson, KSJ Zha, S Hallek, M Moriggl, R Reinhardt, HC Stern, MH Mustjoki, S Newrzela, S Frommolt, P Herling, MNature Communications, 2018

Targeting transcription-coupled nucleotide excision repair overcomes resistance in chronic lymphocytic leukemia

Lohmann, G Vasyutina, E Bloehdorn, J Reinart, N Schneider, J Babu, V Knittel, G Crispatzu, G Mayer, P Prinz, C‎ Biersack, B Efremov, D Chessa, L Herling, CD Stilgenbauer, S Hallek, M Schobert, R Reinhardt, HC Schumacher, B‎ Herling, MLeukemia, 2017

Re-activation of mitochondrial apoptosis inhibits T cell lymphoma survival and treatment resistance

Spinner, S Crispatzu, G Yi JH Munkhbaatar, E Mayer, P Höckendorf, U Müller, N Li, Z Schader, T Bendz, H Hartmann, S Yabal, M Pechloff, K Heikenwalder, M Kelly, GL Strasser, A Peschel, C Hansmann, ML Ruland, J Keller, U Newrzela, SHerling, MJost, PJLeukemia, 2016

The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL

Vasyutina, E Boucas, JM Bloehdorn, J Aszyk, C Crispatzu, G Stiefelhagen, M Breuer, A Mayer, P Lengerke, C Döhner, H Beutner, D Rosenwald, A Stilgenbauer, S Hallek, M Benner, A Herling, MLeukemia, 2015

CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia

Fedorchenko, O Stiefelhagen, M Peer Zada, AA Barthel, R Mayer, P Eckei, L Breuer, A Crispatzu, G Rosen, N Landwehr, T Lilienthal, N Möllmann, M Montesinos-Rongen, M Heukamp, L Dürig, J Hallek, MFingerle-Rowson, GHerling, MBlood, 2013

High TCL1 levels are a marker of B-cell receptor pathway responsiveness and therapy resistance in chronic lymphocytic leukemia

Herling, M Patel, KA Weit, N Lilienthal, N Hallek, M Keating, MJ Jones, DBlood, 2009

High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia

Herling, M Patel, KA Teitell, MA Konopleva, M Ravandi, F Kobayashi, R Jones, DBlood, 2008

TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state

Herling, M Patel, KA Khalili, J Schlette, E Kobayashi, R Medeiros, LJ Jones, DLeukemia, 2006

A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories

Herling, M Khoury, JD Washington, LT Duvic, M Keating, MJ Jones, DBlood, 2004

TCL1 expression in plasmacytoid dendritic cells (DC2) and the related CD4+CD56+ blastic tumors of skin

Herling, M Teitell, MA Shen, RR Medeiros, LJ Jones, DBlood, 2003